Publications by authors named "Thomas Collot"

Claim this Profile
F
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial.
Hélène Bellio, Nicolas Roussot, Aurélie Bertaut, Alice Hervieu, Sylvie Zanetta, Thomas Collot

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment.
Jérémy Barben, Oumar Billa, Julie Collot, Thomas Collot, Patrick Manckoundia

Support Care Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers.
Sandy Chevrier, Corentin Richard, Thomas Collot, Hugo Mananet, Laurent Arnould

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports.
Thomas Collot, Julie Niogret, Marion Carnet, Sandy Chevrier, Etienne Humblin

Mol Med Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and use of whole exome sequencing for metastatic solid cancer.
Manon Réda, Corentin Richard, Aurelie Bertaut, Julie Niogret, Thomas Collot

EBioMedicine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors.
Thomas Collot, Jean-David Fumet, Quentin Klopfenstein, Julie Vincent, Leila Bengrine

Anticancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis